The average P/S ratio for FMS's competitors is 1.87, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS) exhibits a P/S ratio of 0.69, which is -63.31% above the industry average. Given its robust revenue growth of 0.04%, this premium appears unsustainable.